Oh mate where to start..
This company is in an incredible position to take full advantage of the rule change, making money on multiple aspects of it and will be able to perform its trials for MDMA like durgs targeting novel treatments in Australia.
I wrote a whole thing explaining everything about 10 minutes ago but Hotcopper had a moment and its lost now, I'll re write it later but all the information is out there.
Ann: Emyria secures clinical-grade MDMA supply for Aust patients, page-5
Add EMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.29M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 361400 | 3.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.2¢ | 25555 | 1 |
View Market Depth
| Last trade - 10.02am 04/11/2024 (20 minute delay) ? |
| EMD (ASX) Chart |
Day chart unavailable